{
    "status": "ok",
    "totalResults": 18,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Analyzing PetVivo (NASDAQ:PETV) and Haemonetics (NYSE:HAE)",
            "description": "PetVivo (NASDAQ:PETV \u2013 Get Free Report) and Haemonetics (NYSE:HAE \u2013 Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitabilit\u2026",
            "url": "https://www.etfdailynews.com/2023/11/25/analyzing-petvivo-nasdaqpetv-and-haemonetics-nysehae/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-11-25T22:18:41Z",
            "content": "PetVivo (NASDAQ:PETV \u2013 Get Free Report) and Haemonetics (NYSE:HAE \u2013 Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the stren\u2026 [+5591 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "QHSLab (OTCMKTS:USAQ) & Haemonetics (NYSE:HAE) Head to Head Contrast",
            "description": "QHSLab (OTCMKTS:USAQ \u2013 Get Free Report) and Haemonetics (NYSE:HAE \u2013 Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, earnin\u2026",
            "url": "https://www.etfdailynews.com/2023/11/19/qhslab-otcmktsusaq-haemonetics-nysehae-head-to-head-contrast/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-11-19T13:02:42Z",
            "content": "QHSLab (OTCMKTS:USAQ \u2013 Get Free Report) and Haemonetics (NYSE:HAE \u2013 Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the stre\u2026 [+5845 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Haemonetics Co. (NYSE:HAE) Position Cut by Campbell & CO Investment Adviser LLC",
            "description": "Campbell & CO Investment Adviser LLC trimmed its holdings in Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 64.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6\u2026",
            "url": "https://www.etfdailynews.com/2023/12/01/haemonetics-co-nysehae-position-cut-by-campbell-co-investment-adviser-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-12-01T15:26:52Z",
            "content": "Campbell &amp; CO Investment Adviser LLC trimmed its holdings in Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 64.3% in the second quarter, according to its most recent 13F filing with the Securities a\u2026 [+5091 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Royce & Associates LP Acquires 62,538 Shares of Haemonetics Co. (NYSE:HAE)",
            "description": "Royce & Associates LP raised its holdings in Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 7.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 906,292 shares of the medical instru\u2026",
            "url": "https://www.etfdailynews.com/2023/11/05/royce-associates-lp-acquires-62538-shares-of-haemonetics-co-nysehae/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-11-05T14:30:48Z",
            "content": "Royce &amp; Associates LP raised its holdings in Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 7.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commi\u2026 [+5559 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Leukapheresis Market To Worth USD 156.71 Million by 2032 | CAGR of 8.3%",
            "description": "The Global Leukapheresis Market Size was valued at USD 70.60 Million in 2022 and the Worldwide Leukapheresis Market Size is expected to reach USD 156.71 Million by 2032, according to a research report published by Spherical Insights & Consulting. Companies Co\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/16/2781551/0/en/Global-Leukapheresis-Market-To-Worth-USD-156-71-Million-by-2032-CAGR-of-8-3.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-11-16T07:00:00Z",
            "content": "New York, United States, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The Global Leukapheresis Market size is To Grow from USD 70.60 Million in 2022 to USD 156.71 Million by 2032, at a Compound Annual Growth Ra\u2026 [+11157 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Schroder Investment Management Group Boosts Holdings in Haemonetics Co. (NYSE:HAE)",
            "description": "Schroder Investment Management Group raised its holdings in shares of Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 5.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 99\u2026",
            "url": "https://www.etfdailynews.com/2023/11/24/schroder-investment-management-group-boosts-holdings-in-haemonetics-co-nysehae/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-11-24T14:47:13Z",
            "content": "Schroder Investment Management Group raised its holdings in shares of Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 5.3% in the second quarter, according to the company in its most recent disclosure wi\u2026 [+5170 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Triasima Portfolio Management inc. Has $638.59 Million Position in Haemonetics Co. (NYSE:HAE)",
            "description": "Triasima Portfolio Management inc. raised its holdings in shares of Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 33.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,665 shares of\u2026",
            "url": "https://www.etfdailynews.com/2023/11/08/triasima-portfolio-management-inc-has-638-59-million-position-in-haemonetics-co-nysehae/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-11-08T14:26:42Z",
            "content": "Triasima Portfolio Management inc. raised its holdings in shares of Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 33.9% in the 2nd quarter, according to its most recent 13F filing with the Securities a\u2026 [+5314 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Haemonetics Co. (NYSE:HAE) Short Interest Up 7.1% in November",
            "description": "Haemonetics Co. (NYSE:HAE \u2013 Get Free Report) was the target of a significant increase in short interest in November. As of November 15th, there was short interest totalling 1,800,000 shares, an increase of 7.1% from the October 31st total of 1,680,000 shares.\u2026",
            "url": "https://www.etfdailynews.com/2023/12/03/haemonetics-co-nysehae-short-interest-up-7-1-in-november/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-12-03T13:54:41Z",
            "content": "Haemonetics Co. (NYSE:HAE \u2013 Get Free Report) was the target of a significant increase in short interest in November. As of November 15th, there was short interest totalling 1,800,000 shares, an incre\u2026 [+5164 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Capital Research Global Investors Has $569.55 Million Stock Position in Haemonetics Co. (NYSE:HAE)",
            "description": "Capital Research Global Investors lifted its stake in Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 0.5% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,689,539 shares of the medical in\u2026",
            "url": "https://www.etfdailynews.com/2023/11/23/capital-research-global-investors-has-569-55-million-stock-position-in-haemonetics-co-nysehae/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-11-23T16:34:51Z",
            "content": "Capital Research Global Investors lifted its stake in Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 0.5% during the 2nd quarter, according to its most recent 13F filing with the Securities &amp; Exchan\u2026 [+4765 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Haemonetics Co. (NYSE:HAE) Shares Purchased by Dean Investment Associates LLC",
            "description": "Dean Investment Associates LLC lifted its holdings in Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 69.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,902 shares \u2026",
            "url": "https://www.etfdailynews.com/2023/11/06/haemonetics-co-nysehae-shares-purchased-by-dean-investment-associates-llc/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-11-06T13:22:46Z",
            "content": "Dean Investment Associates LLC lifted its holdings in Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 69.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities &amp; Exch\u2026 [+5287 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Vise Technologies Inc. Grows Holdings in Haemonetics Co. (NYSE:HAE)",
            "description": "Vise Technologies Inc. grew its position in shares of Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 57.9% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,23\u2026",
            "url": "https://www.etfdailynews.com/2023/11/10/vise-technologies-inc-grows-holdings-in-haemonetics-co-nysehae/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-11-10T14:05:03Z",
            "content": "Vise Technologies Inc. grew its position in shares of Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 57.9% during the 2nd quarter, according to the company in its most recent filing with the Securities \u2026 [+5406 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "London Co. of Virginia Increases Stock Position in Haemonetics Co. (NYSE:HAE)",
            "description": "London Co. of Virginia raised its stake in shares of Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 0.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor own\u2026",
            "url": "https://www.etfdailynews.com/2023/12/02/london-co-of-virginia-increases-stock-position-in-haemonetics-co-nysehae/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-12-02T16:48:43Z",
            "content": "London Co. of Virginia raised its stake in shares of Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 0.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Secu\u2026 [+4859 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Arjuna Capital Has $1.76 Million Holdings in Haemonetics Co. (NYSE:HAE)",
            "description": "Arjuna Capital boosted its position in shares of Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 1.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,678 shares of \u2026",
            "url": "https://www.etfdailynews.com/2023/11/13/arjuna-capital-has-1-76-million-holdings-in-haemonetics-co-nysehae/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-11-13T16:44:58Z",
            "content": "Arjuna Capital boosted its position in shares of Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 1.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and\u2026 [+4789 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Great Lakes Advisors LLC Purchases 16,569 Shares of Haemonetics Co. (NYSE:HAE)",
            "description": "Great Lakes Advisors LLC increased its position in shares of Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 10.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 179,86\u2026",
            "url": "https://www.etfdailynews.com/2023/11/18/great-lakes-advisors-llc-purchases-16569-shares-of-haemonetics-co-nysehae/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/haemonetics-co-logo.png?v=20221117093105&w=240&h=240&zc=2",
            "publishedAt": "2023-11-18T18:54:55Z",
            "content": "Great Lakes Advisors LLC increased its position in shares of Haemonetics Co. (NYSE:HAE \u2013 Free Report) by 10.1% during the second quarter, according to the company in its most recent disclosure with t\u2026 [+4459 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Microbot Medical Inc.",
            "title": "Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities",
            "description": "The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the clinical and regulatory phase. The former Senior Medical Director for the Peripheral Interventions Divisio\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/11/21/2784122/0/en/Microbot-Medical-Appoints-Seasoned-Medical-Expert-Dr-Juan-Diaz-Cartelle-as-its-New-Chief-Medical-Officer-in-Anticipation-of-Its-Clinical-Regulatory-and-Commercial-Activities.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/3a6663db-de72-4ae6-986e-78445cf43bb0",
            "publishedAt": "2023-11-21T14:12:00Z",
            "content": "BRAINTREE, Mass., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY\u00ae Endovascular Robotic Surgical System, today announced the appointment of\u2026 [+5950 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities",
            "description": "(marketscreener.com) The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the clinical and regulatory phase.BRAINTREE, Mass., Nov. 21, 2023 -- Microbot Medical Inc\u2026",
            "url": "https://www.marketscreener.com/quote/stock/MICROBOT-MEDICAL-INC-45615636/news/Microbot-Medical-Appoints-Seasoned-Medical-Expert-Dr-Juan-Diaz-Cartelle-as-its-New-Chief-Medical-O-45408580/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-11-21T14:13:01Z",
            "content": "The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the clinical and regulatory phase.\r\nBRAINTREE, Mas\u2026 [+6142 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Royce Value Trust (NYSE: RVT) as of Oct 31, 2023",
            "description": "(marketscreener.com) \n\nNEW YORK, Nov. 27, 2023 /PRNewswire/ --\n\nOldest and largest small-cap closed-end fundAverage weekly trading volume of approximately 1,430,293 sharesFund's adviser has more than 40 years of small- and micro-cap investment experienceCLOSI\u2026",
            "url": "https://www.marketscreener.com/quote/stock/ROYCE-VALUE-TRUST-INC-14305/news/Royce-Value-Trust-NYSE-RVT-as-of-Oct-31-2023-45444630/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-11-27T19:00:03Z",
            "content": "NEW YORK, Nov. 27, 2023 /PRNewswire/ --\r\n<ul><li>Oldest and largest small-cap closed-end fund</li><li>Average weekly trading volume of approximately 1,430,293 shares</li><li>Fund's adviser has more t\u2026 [+5677 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Opsens : Management's Discussion & analysis for the year 2023",
            "description": "(marketscreener.com) \n \n MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND\n \n \n RESULTS OF OPERATIONS FOR THE YEAR ENDED AUGUST 31, 2023\n \n \n The following comments are intended to provide a review and analysis of the results of operations, fina\u2026",
            "url": "https://www.marketscreener.com/quote/stock/OPSENS-INC-1411137/news/Opsens-Management-s-Discussion-analysis-for-the-year-2023-45420253/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-11-22T16:54:01Z",
            "content": "MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND\r\nRESULTS OF OPERATIONS FOR THE YEAR ENDED AUGUST 31, 2023\r\nThe following comments are intended to provide a review and analysis of the \u2026 [+36363 chars]"
        }
    ]
}